Largest genetic study of heart failure finds new risk factors

In a new study co-led by investigators at the United States Department of Veterans Affairs and Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, a global team of scientists conducted one of the largest genetic association studies on heart failure to date.

BMS, VantAI team up; CRISPR Therapeutics to raise $280M; Ono Pharma’s deal with Shattuck Labs

Plus, news about Areteia Therapeutics, Sudo Biosciences, Cidara Therapeutics, Xspray Pharma and Sana Biotechnology: Bristol Myers Squibb inks deal with VantAI: The pair plan to

February 14, 2024

Pharmalittle: We’re reading about Amazon delivering Zepbound, hemophilia treatments, and more

Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more

March 13, 2024

CST and Leica Biosystems join forces to develop companion diagnostics for personalized medicine

Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, is partnered with Leica Biosystems, a technology leader

September 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.